Schneeberger, S <br/><br/>
Alemtuzumab: key for minimization of maintenance immunosuppression in reconstructive transplantation?  [electronic resource] 

 -  Transplantation proceedings  Mar 2009 
 - 499-502 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0041-1345 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2009.01.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alemtuzumab<br/>Amputation, Surgical<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antibodies, Neoplasm--therapeutic use<br/>Arm--transplantation<br/>Austria<br/>Female<br/>Forearm--surgery<br/>Functional Laterality<br/>Hand Transplantation<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppression Therapy--methods<br/>Male<br/>Middle Aged<br/>Plastic Surgery Procedures--methods<br/>Spain<br/>Transplantation Immunology<br/>Transplantation, Homologous--immunology<br/>United States<br/>Young Adult